These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12237943)

  • 1. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
    Wilder PJ; Bernadt CT; Kim JH; Rizzino A
    Mol Reprod Dev; 2002 Nov; 63(3):282-90. PubMed ID: 12237943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
    Bernadt CT; Rizzino A
    Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-beta 2 gene.
    Scholtz B; Kelly D; Rizzino A
    Mol Reprod Dev; 1995 Jun; 41(2):140-8. PubMed ID: 7654367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the transforming growth factor-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells: differential utilization of transcription factors.
    Kelly D; Scholtz B; Orten DJ; Hinrichs SH; Rizzino A
    Mol Reprod Dev; 1995 Feb; 40(2):135-45. PubMed ID: 7766406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
    Jackson RJ; Antonia SJ; Wright KL; Moon NS; Nepveu A; Muñoz-Antonia T
    Arch Biochem Biophys; 1999 Nov; 371(2):290-300. PubMed ID: 10545217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
    Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
    Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
    Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.
    Kelly D; Kim SJ; Rizzino A
    J Biol Chem; 1998 Aug; 273(33):21115-24. PubMed ID: 9694866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region.
    Hou J; Wilder PJ; Bernadt CT; Boer B; Neve RM; Rizzino A
    Gene; 2004 Sep; 340(1):123-31. PubMed ID: 15556300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes.
    Jin Y; Sheikh F; Detillieux KA; Cattini PA
    Mol Pharmacol; 2000 May; 57(5):984-90. PubMed ID: 10779383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
    Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary homeobox 1 (Pitx1) stimulates rat LHbeta gene expression via two functional DNA-regulatory regions.
    Jiang Q; Jeong KH; Horton CD; Halvorson LM
    J Mol Endocrinol; 2005 Aug; 35(1):145-58. PubMed ID: 16087728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
    Liu C; Calogero A; Ragona G; Adamson E; Mercola D
    Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.